Liquid Trace™
Detects Actionable Mutations in Plasma
Analyzes over 1,500 genes (DNA & RNA)
Identifies key gene amplifications, including HER2, FGFR, PI3KCA, and RAS
Identifies key fusions, MRD, HRR, HPV/EBV
Gene expression & alternative splicing
Chromosomal abnormalities including gene amplification
Matches targeted therapy options and immune therapy options to test results
Recurrence monitoring
Turn-around Time: 7 business days
CellSearch®
Circulating Tumor Cells
Isolates and counts cancer cells
Measures HER2 low, PDL1 or ER
FDA cleared for patients with breast, colon, prostate, gallbladder/biliary tract, and anal cancer
Measures a patients response to therapy over time through serial testing
Turn-around Time: 7 business days
Note: CellSearch® is now available for patients with Multiple Myeloma and Melanoma to quantitatively monitor residual disease.
OnkoSkan™
Measures hPG80 to Detect and Monitor Cancer
hPG80 (Circulating Progastrin), is a new blood based biomarker that detects cancer
OnkoSkan™ aids in both screening and TRT monitoring for most cancers
Measures hPG80, a biomarker associated with cancer activity
Applicable to 16 cancer types, across all stages (view full list here>)
For non-pregnant women and men over the age of 18
Turn-around Time: 2-5 business days
Request more information on Protean’s Liquid Biopsy Tests:
Enter your name and email address below and someone from Protean’s team will reach out to you.
Contact Us for Information or to Order a Test:
Phone: +1 (754) 242 9682 | Email: support@proteanbiodx.com
